$70.02
+0.48 (+0.69%)
Open$68.50
Previous Close$69.54
Day High$71.00
Day Low$68.00
52W High$97.97
52W Low$4.11
Volume—
Avg Volume30.6K
Market Cap247.17M
P/E Ratio—
EPS$-2.20
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
-82.3% upside
Current
$70.02
$70.02
Target
$12.40
$12.40
$7.31
$12.40 avg
$17.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 22.05M | 12.90M | 80.43M |
| Net Income | -6,967,411 | -3,667,916 | 27.17M |
| Profit Margin | -31.6% | -30.0% | 33.8% |
| EBITDA | -8,448,141 | -4,694,509 | 38.14M |
| Free Cash Flow | — | — | 15.33M |
| Rev Growth | +71.0% | +71.0% | -4.6% |
| Debt/Equity | — | — | 0.36 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |